Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET
- 6 May 2010
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 37 (5) , 565-575
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Hypoxia, HIF1 and glucose metabolism in the solid tumourNature Reviews Cancer, 2008
- Molecular Imaging of HypoxiaJournal of Nuclear Medicine, 2008
- Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy responseNature Reviews Cancer, 2008
- Hypoxia Positron Emission Tomography Imaging With 18F-FluoromisonidazoleSeminars in Nuclear Medicine, 2007
- Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancerBritish Journal of Cancer, 2007
- Hypoxia, gene expression, and metastasisCancer and Metastasis Reviews, 2007
- Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pHFEBS Letters, 2004
- In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomographyBritish Journal of Cancer, 2004
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1988
- A marker for hypoxic cells in tumours with potential clinical applicabilityBritish Journal of Cancer, 1981